Patents Assigned to MODMAB THERAPEUTICS CORPORATION
  • Frizzled5 protein-binding agents
    Patent number: 10919968
    Abstract: The present disclosure is directed to novel FZD5-binding agents and methods and uses thereof for treating a disease or disorder associated with aberrant expression or activity of Frizzled protein.
    Type: Grant
    Filed: January 27, 2017
    Date of Patent: February 16, 2021
    Assignee: MODMAB THERAPEUTICS CORPORATION
    Inventors: Sachdev Sidhu, Jason Moffat, Stephane Angers, Zachary Steinhart